SCM
AZN icon

Segantii Capital Management’s AstraZeneca AZN Stock Holding History

Segantii Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-74,292
Closed -$7.39M – 510
2021
Q1 		$7.39M Buy
+74,292
New +$7.47M 0.32% 68
2020
Q1 		– Sell
-40,805
Closed -$4.08M – 68
2019
Q4 		$4.08M Sell
40,805
-2,750
-6% -$259K 0.3% 53
2019
Q3 		$3.89M Buy
+43,555
New +$3.78M 0.53% 35

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Segantii Capital Management's AZN Position: Q2 2021 in Review

Segantii Capital Management sold out of AstraZeneca (AZN) in Q2 2021, closing a stake of 74,292 shares — an estimated $7.39M sold.

Segantii Capital Management first reported a position in AZN in Q3 2019 and held it in 3 quarters. The position peaked at $7.39M in Q1 2021. 771 funds tracked by Wall St. Rank hold AZN as of Q2 2021.

  • Segantii Capital Management reported no remaining AstraZeneca position as of Q2 2021 after selling out during the quarter.
  • Segantii Capital Management sold 74,292 AstraZeneca shares in Q2 2021, an estimated $7.39M.
  • Segantii Capital Management first reported a position in AstraZeneca in Q3 2019 and held it in 3 quarters.
  • Segantii Capital Management's AstraZeneca position peaked at $7.39M in Q1 2021.
  • 771 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.

Based on Segantii Capital Management's 13F filing for Q2 2021, filed 6 Aug 2021.